842 related articles for article (PubMed ID: 15872359)
1. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.
Dewaraja YK; Wilderman SJ; Ljungberg M; Koral KF; Zasadny K; Kaminiski MS
J Nucl Med; 2005 May; 46(5):840-9. PubMed ID: 15872359
[TBL] [Abstract][Full Text] [Related]
2. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
[TBL] [Abstract][Full Text] [Related]
3. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
Sgouros G; Kolbert KS; Sheikh A; Pentlow KS; Mun EF; Barth A; Robbins RJ; Larson SM
J Nucl Med; 2004 Aug; 45(8):1366-72. PubMed ID: 15299063
[TBL] [Abstract][Full Text] [Related]
4. Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.
Sgouros G; Squeri S; Ballangrud AM; Kolbert KS; Teitcher JB; Panageas KS; Finn RD; Divgi CR; Larson SM; Zelenetz AD
J Nucl Med; 2003 Feb; 44(2):260-8. PubMed ID: 12571219
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
Prideaux AR; Song H; Hobbs RF; He B; Frey EC; Ladenson PW; Wahl RL; Sgouros G
J Nucl Med; 2007 Jun; 48(6):1008-16. PubMed ID: 17504874
[TBL] [Abstract][Full Text] [Related]
6. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
[TBL] [Abstract][Full Text] [Related]
7. Initial results for Hybrid SPECT--conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphoma.
Koral KF; Dewaraja Y; Li J; Barrett CL; Regan DD; Zasadny KR; Rommelfanger SG; Francis IR; Kaminski MS; Wahl RL
J Nucl Med; 2000 Sep; 41(9):1579-86. PubMed ID: 10994741
[TBL] [Abstract][Full Text] [Related]
8. Effect of image registration on 3D absorbed dose calculations in
Grassi E; Fioroni F; Berenato S; Patterson N; Ferri V; Braglia L; Filice A; Versari A; Iori M; Spezi E
Phys Med; 2018 Jan; 45():177-185. PubMed ID: 29472084
[TBL] [Abstract][Full Text] [Related]
9. A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using monte carlo simulation.
Ljungberg M; Sjögreen K; Liu X; Frey E; Dewaraja Y; Strand SE
J Nucl Med; 2002 Aug; 43(8):1101-9. PubMed ID: 12163637
[TBL] [Abstract][Full Text] [Related]
10. Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient study.
Dewaraja YK; Wilderman SJ; Koral KF; Kaminski MS; Avram AM
Cancer Biother Radiopharm; 2009 Aug; 24(4):417-26. PubMed ID: 19694576
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional portal image-based dose reconstruction in a virtual phantom for rapid evaluation of IMRT plans.
Ansbacher W
Med Phys; 2006 Sep; 33(9):3369-82. PubMed ID: 17022233
[TBL] [Abstract][Full Text] [Related]
12. A Monte Carlo and physical phantom evaluation of quantitative In-111 SPECT.
He B; Du Y; Song X; Segars WP; Frey EC
Phys Med Biol; 2005 Sep; 50(17):4169-85. PubMed ID: 16177538
[TBL] [Abstract][Full Text] [Related]
13. Quantification and reduction of the collimator-detector response effect in SPECT by applying a system model during iterative image reconstruction: a simulation study.
Kalantari F; Rajabi H; Saghari M
Nucl Med Commun; 2012 Mar; 33(3):228-38. PubMed ID: 22134173
[TBL] [Abstract][Full Text] [Related]
14. Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology.
Pacilio M; Ferrari M; Chiesa C; Lorenzon L; Mira M; Botta F; Becci D; Torres LA; Coca Perez M; Vergara Gil A; Basile C; Ljungberg M; Pani R; Cremonesi M
Med Phys; 2016 Jul; 43(7):4053. PubMed ID: 27370124
[TBL] [Abstract][Full Text] [Related]
15. 3D absorbed dose calculations based on SPECT: evaluation for 111-In/90-Y therapy using Monte Carlo simulations.
Ljungberg M; Frey E; Sjögreen K; Liu X; Dewaraja Y; Strand SE
Cancer Biother Radiopharm; 2003 Feb; 18(1):99-107. PubMed ID: 12667313
[TBL] [Abstract][Full Text] [Related]
16. VIDA: a voxel-based dosimetry method for targeted radionuclide therapy using Geant4.
Kost SD; Dewaraja YK; Abramson RG; Stabin MG
Cancer Biother Radiopharm; 2015 Feb; 30(1):16-26. PubMed ID: 25594357
[TBL] [Abstract][Full Text] [Related]
17. Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy.
Giap HB; Macey DJ; Podoloff DA
J Nucl Med; 1995 Oct; 36(10):1885-94. PubMed ID: 7562060
[TBL] [Abstract][Full Text] [Related]
18. Fast 3D iterative image reconstruction for SPECT with rotating slat collimators.
Holen RV; Vandenberghe S; Staelens S; De Beenhouwer J; Lemahieu I
Phys Med Biol; 2009 Feb; 54(3):715-29. PubMed ID: 19131666
[TBL] [Abstract][Full Text] [Related]
19. The importance of the accuracy of image registration of SPECT images for 3D targeted radionuclide therapy dosimetry.
Papavasileiou P; Divoli A; Hatziioannou K; Flux GD
Phys Med Biol; 2007 Dec; 52(24):N539-48. PubMed ID: 18065833
[TBL] [Abstract][Full Text] [Related]
20. Comparison of I-131 radioimmunotherapy tumor dosimetry: unit density sphere model versus patient-specific Monte Carlo calculations.
Howard DM; Kearfott KJ; Wilderman SJ; Dewaraja YK
Cancer Biother Radiopharm; 2011 Oct; 26(5):615-21. PubMed ID: 21939358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
